Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1561 USD | +4.07% |
|
-2.44% | -27.80% |
Jun. 18 | Transcript : Matinas BioPharma Holdings, Inc. - Special Call | |
Jun. 13 | Matinas Biopharma Holdings, Inc.'s Oral MAT2203 Featured in Fireside Chat | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.80% | 37.62M | |
+15.85% | 121B | |
+18.91% | 112B | |
+4.43% | 22.57B | |
-18.63% | 20.82B | |
-13.76% | 16.3B | |
-16.61% | 16.19B | |
-43.53% | 16.17B | |
+1.75% | 13.17B | |
+28.07% | 11.11B |
- Stock Market
- Equities
- MTNB Stock
- News Matinas BioPharma Holdings, Inc.
- Matinas Biopharma Holdings, Inc. Announces Termination of Dominick M. Dipaolo as Its Senior Vice President of Quality and Regulatory Compliance